NOVA SOUTHEASTERN UNIVERSITY

Alzheimer’s disease research shifts focus from amyloid hypothesis to gene therapy, aiming to convert bad genetics to good in the brain. Researchers use viral vectors to deliver protective genes, like APOE2, to combat Alzheimer’s. Early results show promise, with decreased tau protein levels and no significant adverse events. Challenges include immune response to AAV vectors and therapy affordability.

ZEO ScientifiX launches monthly educational events for healthcare providers, focusing on regenerative medicine and practical business tools. The events include expert discussions, lab tours, and networking opportunities, aiming to help physicians integrate biologic therapies into their practices. ZEO recently completed Phase 1 trials for its product Zofin™ and plans to launch Phase 2 trials.

ZEO ScientifiX launches regenerative medicine educational series for physicians, offering practical business tools and research insights. The monthly events include expert discussions, lab tours, and networking opportunities, aiming to help doctors integrate regenerative medicine into their practices. ZEO also seeks to advance its clinical trials and obtain FDA approval for its products.